Methylprednisolone Hemisuccinate
Showing 1 - 25 of 830
Sudden Hearing Loss, Obstructive Sleep Apnea Trial in Beijing (non-invasive positive airway pressure, Methylprednisolone
Recruiting
- Sudden Hearing Loss
- Obstructive Sleep Apnea
- non-invasive positive airway pressure
- +2 more
-
Beijing, Beijing, ChinaBeijing Tsinhgua Changgung Hospital
Dec 9, 2019
Elective Cardiac Surgery Trial in Ghent (Methylprednisolone, Placebo)
Completed
- Elective Cardiac Surgery
- Methylprednisolone
- Placebo
-
Ghent, BelgiumUniversity Hospital Ghent
Dec 6, 2022
Toxic Epidermal Necrolysis Trial in Fuzhou (Abrocitinib)
Recruiting
- Toxic Epidermal Necrolysis
-
Fuzhou, Fujian, ChinaDepartment of Dermatology, the First Affiliated Hospital of Fuji
Oct 31, 2023
Knee Osteoarthritis Trial (ACP Max™, Depo-Medrol®)
Not yet recruiting
- Knee Osteoarthritis
- ACP Max™
- Depo-Medrol®
- (no location specified)
Mar 1, 2023
Caudal Block Trial (caudal block using dexamethasone, caudal block using methylprednisolone)
Not yet recruiting
- Caudal Block
- caudal block using dexamethasone
- caudal block using methylprednisolone
- (no location specified)
Jan 28, 2023
Steroid Metabolism in Obese and Non-Obese Pediatric Patients
Completed
- Pediatric Obesity
- Asthma in Children
-
Durham, North CarolinaDuke University Hospital
Jun 30, 2022
Cyanotic Heart Disease, Cardiopulmonary Bypass Trial in Karachi (Methylprednisolone, Saline)
Recruiting
- Cyanotic Heart Disease
- Cardiopulmonary Bypass
-
Karachi, Sindh, PakistanAga Khan University Hospital
Jun 30, 2023
Methylprednisone Administration, Intranasal Administration, Intravenous Administration Trial in Mexico City (Evaluation of
Completed
- Methylprednisone Administration
- +3 more
- Evaluation of bioavailability of methylprednisolone succinate administered intravenously
- Evaluation of bioavailability of methylprednisolone succinate administered intranasally
-
Mexico City, MexicoUniversidad Nacional Autonoma de Mexico
Dec 13, 2022
Toxic Optic Neuropathy, Treatment, Methylprednisolone Trial in Ciudad de mexico (Recombinant human erythropoietin 4,000 UI and
Recruiting
- Toxic Optic Neuropathy
- +3 more
- Recombinant human erythropoietin 4,000 UI and 2,000 UI
- Methylprednisolone succinate 500 mg
-
Ciudad de mexico, MexicoJorge Cárdenas Belaunzarán
Feb 20, 2023
Multiple Sclerosis Trial in Clermont-Ferrand (Methylprednisolone, Placebo, natalizumab (NTZ))
Recruiting
- Multiple Sclerosis
- Methylprednisolone
- +3 more
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Jan 5, 2023
Rhinitis, Allergic, Seasonal, Hay Fever, Pollen Allergy Trial in Lund (MethylPREDNISolone 40 Mg/mL Injectable Suspension, NaCl 9
Active, not recruiting
- Rhinitis, Allergic, Seasonal
- +3 more
- MethylPREDNISolone 40 Mg/mL Injectable Suspension
- NaCl 9 MG/ML Injectable Solution
-
Lund, Skane, SwedenDepartment of Lung-and Allergy Research
Jun 22, 2022
Total Knee Arthroplasty Trial in Oak Brook (Methylprednisolone, Placebo)
Recruiting
- Total Knee Arthroplasty
- Methylprednisolone
- Placebo
-
Oak Brook, IllinoisRush Oak Brook Outpatient Center
Nov 15, 2022
Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,
Recruiting
- Lupus Nephritis
- +2 more
- Methylprednisolone Injectable Suspension
- +2 more
-
Nanjing, Jiangsu, ChinaJiong Zhang
May 8, 2023
Knee Arthritis Trial in Atlanta, Tucker (Methylprednisolone, Standard of Care)
Not yet recruiting
- Knee Arthritis
- Methylprednisolone
- Standard of Care
-
Atlanta, Georgia
- +1 more
May 5, 2023
Methylprednisolone, Glucocorticoid, Aortic Dissection Trial (Methylprednisolone Injection)
Recruiting
- Methylprednisolone
- +3 more
- Methylprednisolone Injection
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Oct 25, 2022
Plantar Fascitis Trial in Minya (platelet rich plasma, MethylPREDNISolone 40 MG)
Completed
- Plantar Fascitis
- platelet rich plasma
- MethylPREDNISolone 40 MG
-
Minya, EgyptMinya university
Jul 2, 2022
Heart Block, Aortic Stenosis, Bundle-Branch Block Trial in Alicante (Methylprednisolone, Placebo)
Recruiting
- Heart Block
- +2 more
- Methylprednisolone
- Placebo
-
Alicante, SpainGeneral University Hospital of Alicante
Oct 3, 2023
Macrophage Activation Syndrome Trial (Ruxolitinib, methylprednisolone)
Not yet recruiting
- Macrophage Activation Syndrome
- (no location specified)
Mar 16, 2022
Pneumonitis, Malignant Tumor Trial in Guangzhou (Pirfenidone, methylprednisolone, Methylprednisolone)
Recruiting
- Pneumonitis
- Malignant Tumor
- Pirfenidone, methylprednisolone
- Methylprednisolone
-
Guangzhou, Guangdong, ChinaZhou Chengzhi
Mar 6, 2022
GVHD,Acute, Stem Cell Transplant Complications Trial in Chengdu (Methylprednisolone)
Recruiting
- GVHD,Acute
- Stem Cell Transplant Complications
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
May 9, 2022
Post-COVID-19 Syndrome Trial in Berlin (Methylprednisolone)
Not yet recruiting
- Post-COVID-19 Syndrome
-
Berlin, GermanyCharité - Universitätsmedizin Berlin
Aug 9, 2023
NSCLC Trial in Guangzhou (chest radiation, concurrent chemo, Methylprednisolone)
Terminated
- Non-small Cell Lung Cancer
- chest radiation
- +2 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Nov 25, 2022
Chidamide, Hemophagocytic Lymphohistiocytosis Trial in Beijing (Chidamide combines with VP-16 and methylprednisolone)
Recruiting
- Chidamide
- Hemophagocytic Lymphohistiocytosis
- Chidamide combines with VP-16 and methylprednisolone
-
Beijing, Beijing, ChinaBeijing Friendship Hospital
Nov 29, 2021